BOSTON — Vertex Pharmaceuticals reshaped the way doctors treat cystic fibrosis, turning what was once a childhood death sentence into a manageable condition — and making the Boston biotech a multi-billion-dollar company in the process.
Its next goal? Reproducing that success.